STSA Satsuma Pharmaceuticals, Inc. - 10-K/A
Filed Apr 28, 2023 for fiscal period ending Dec 31, 2022. See issuer overview · financials · original on SEC.gov ↗
Accession
0000950170-23-015782Signal
Neutralfull-docYoY shift: Unscored
Year-over-year tone shift - average net-tone change across Risk Factors and MD&A vs the prior 10-K.
Why YoY instead of absolute: the LM lexicon has ~6.6× more negative words than positive (legal/risk-disclosure language is heavy on hedging), so every 10-K reads bearish on raw tone. Year-over-year change strips that bias and surfaces the actual shift in management's framing.
Per-snippet highlights
Sentence-level sentiment highlighting with category and subcategory filters is coming once the snippet-scoring pipeline lands. For now, dig into the actual section text on the Sections tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
No section text extracted for this filing. The 10-K may use a non-standard template that the parser doesn't recognize - the original doc is still linked in the Stats tab.
Material contracts, certifications & more
5 exhibits filed with this 10-K
- Exhibit 31.1: Rule 13a-14(a) Certification (CEO)stsa-ex31_1.htm · 20.5 KB
- Exhibit 31.2: Rule 13a-14(a) Certification (CFO)stsa-ex31_2.htm · 20.3 KB
- Exhibit 32.1: Section 1350 Certification (CEO)stsa-ex32_1.htm · 11.8 KB
- Exhibit 32.2: Section 1350 Certification (CFO)stsa-ex32_2.htm · 11.8 KB
- 0000950170-23-015782-index-headers.html0000950170-23-015782-index-headers.html
- Ticker
- STSA
- CIK
0001692830- Form Type
- 10-K/A
- Accession Number
0000950170-23-015782- Filed
- Apr 28, 2023
- Period
- Dec 31, 2022 (Q4 22)
- Industry
- Pharmaceutical Preparations
External resources
Permalink
https://insiderdelta.com/issuers/STSA/10-k/0000950170-23-015782